p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer

G. Esposito, S. Pucciarelli, R. Alaggio, L. Giacomelli, E. Marchiori, G. A. Iaderosa, M. L. Friso, P. Toppan, L. Chieco-Bianchi, M. Lise

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background: Our aim was to ascertain whether or not the response to preoperative chemoradiotherapy for rectal cancer is associated with p27kip1 and p53 protein expression. Methods: Thirty-eight patients (27 male, 11 female) with a mean age of 59 years (age range 33-87) and stage II-III rectal cancer received preoperative chemoradiotherapy (45-50.4 Gy; 5-FU 350 mg/m2/day and leucovorin 10 mg/m2/day). Thirty-one underwent low anterior resection; seven underwent abdominoperineal excision. Endoscopic tumor biopsies, performed before adjuvant therapy, were evaluated for: histologic type, tumor differentiation, mitotic index, and p27kip1 and p53 protein expression which were immunohistochemically determined. p53 expression was graded as: a) absent or present in ≤10% of tumor cells; b) present in 11-25%; c) present in 26-75%; and d) present in >75% of tumor cells. p27kip1 expression was assessed using both light microscopy (percent of stained cells x10 HPF) and cytometry with an image analysis workstation. Tumor response, ascertained with histology, was classified using a scale from 0 (no response) to 6 (complete pathologic response). Results: The mitotic index for the endoscopic biopsies was low in 14 cases, moderate in 17 cases, and high in 7 cases. p53 protein expression was found in 21 (a), 3 (b), 3 (c), and 11 (d) cases. The mean percentage of cells expressing the p27kip1 protein was 34 (range 0-77.14%). A close correlation was found between cytometric and light microscopy findings for p27kip1 (r2 = 0.92, P = .0001). Tumor differentiation was good in 5 cases, poor in 2 cases, and moderate in the remaining 31 cases. While the response to adjuvant therapy was good/complete in 25 (65.78%) cases, it was absent/poor in 13 (34.21%) cases. Univariate analysis associated type of adjuvant therapy (chemoradiotherapy, P = .0428) and p27kip1 protein lower expression (P = .0148) with a poor response to adjuvant treatment. Stepwise linear regression found overexpression of p53 and p27kip1 and young age to be independent variables that were linked to a good response to adjuvant therapy. Conclusions: Lack of p27kip1 and p53 protein expression in rectal cancer is associated with a poor response to preoperative adjuvant therapy.

Original languageEnglish
Pages (from-to)311-318
Number of pages8
JournalAnnals of Surgical Oncology
Volume8
Issue number4
DOIs
Publication statusPublished - 2001

Fingerprint

Cyclin-Dependent Kinase Inhibitor p27
Chemoradiotherapy
Rectal Neoplasms
Neoplasms
Mitotic Index
Microscopy
Therapeutics
Adjuvant Chemoradiotherapy
Image Cytometry
Biopsy
Light
Leucovorin
Fluorouracil
Linear Models
Histology
Proteins

Keywords

  • Chemoradiotherapy
  • p27
  • p53
  • Rectal cancer

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Esposito, G., Pucciarelli, S., Alaggio, R., Giacomelli, L., Marchiori, E., Iaderosa, G. A., ... Lise, M. (2001). p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Annals of Surgical Oncology, 8(4), 311-318. https://doi.org/10.1245/aso.2001.8.4.311

p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. / Esposito, G.; Pucciarelli, S.; Alaggio, R.; Giacomelli, L.; Marchiori, E.; Iaderosa, G. A.; Friso, M. L.; Toppan, P.; Chieco-Bianchi, L.; Lise, M.

In: Annals of Surgical Oncology, Vol. 8, No. 4, 2001, p. 311-318.

Research output: Contribution to journalArticle

Esposito, G, Pucciarelli, S, Alaggio, R, Giacomelli, L, Marchiori, E, Iaderosa, GA, Friso, ML, Toppan, P, Chieco-Bianchi, L & Lise, M 2001, 'p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer', Annals of Surgical Oncology, vol. 8, no. 4, pp. 311-318. https://doi.org/10.1245/aso.2001.8.4.311
Esposito, G. ; Pucciarelli, S. ; Alaggio, R. ; Giacomelli, L. ; Marchiori, E. ; Iaderosa, G. A. ; Friso, M. L. ; Toppan, P. ; Chieco-Bianchi, L. ; Lise, M. / p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. In: Annals of Surgical Oncology. 2001 ; Vol. 8, No. 4. pp. 311-318.
@article{890835fe049846228540ef487a6b3f69,
title = "p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer",
abstract = "Background: Our aim was to ascertain whether or not the response to preoperative chemoradiotherapy for rectal cancer is associated with p27kip1 and p53 protein expression. Methods: Thirty-eight patients (27 male, 11 female) with a mean age of 59 years (age range 33-87) and stage II-III rectal cancer received preoperative chemoradiotherapy (45-50.4 Gy; 5-FU 350 mg/m2/day and leucovorin 10 mg/m2/day). Thirty-one underwent low anterior resection; seven underwent abdominoperineal excision. Endoscopic tumor biopsies, performed before adjuvant therapy, were evaluated for: histologic type, tumor differentiation, mitotic index, and p27kip1 and p53 protein expression which were immunohistochemically determined. p53 expression was graded as: a) absent or present in ≤10{\%} of tumor cells; b) present in 11-25{\%}; c) present in 26-75{\%}; and d) present in >75{\%} of tumor cells. p27kip1 expression was assessed using both light microscopy (percent of stained cells x10 HPF) and cytometry with an image analysis workstation. Tumor response, ascertained with histology, was classified using a scale from 0 (no response) to 6 (complete pathologic response). Results: The mitotic index for the endoscopic biopsies was low in 14 cases, moderate in 17 cases, and high in 7 cases. p53 protein expression was found in 21 (a), 3 (b), 3 (c), and 11 (d) cases. The mean percentage of cells expressing the p27kip1 protein was 34 (range 0-77.14{\%}). A close correlation was found between cytometric and light microscopy findings for p27kip1 (r2 = 0.92, P = .0001). Tumor differentiation was good in 5 cases, poor in 2 cases, and moderate in the remaining 31 cases. While the response to adjuvant therapy was good/complete in 25 (65.78{\%}) cases, it was absent/poor in 13 (34.21{\%}) cases. Univariate analysis associated type of adjuvant therapy (chemoradiotherapy, P = .0428) and p27kip1 protein lower expression (P = .0148) with a poor response to adjuvant treatment. Stepwise linear regression found overexpression of p53 and p27kip1 and young age to be independent variables that were linked to a good response to adjuvant therapy. Conclusions: Lack of p27kip1 and p53 protein expression in rectal cancer is associated with a poor response to preoperative adjuvant therapy.",
keywords = "Chemoradiotherapy, p27, p53, Rectal cancer",
author = "G. Esposito and S. Pucciarelli and R. Alaggio and L. Giacomelli and E. Marchiori and Iaderosa, {G. A.} and Friso, {M. L.} and P. Toppan and L. Chieco-Bianchi and M. Lise",
year = "2001",
doi = "10.1245/aso.2001.8.4.311",
language = "English",
volume = "8",
pages = "311--318",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York LLC",
number = "4",

}

TY - JOUR

T1 - p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer

AU - Esposito, G.

AU - Pucciarelli, S.

AU - Alaggio, R.

AU - Giacomelli, L.

AU - Marchiori, E.

AU - Iaderosa, G. A.

AU - Friso, M. L.

AU - Toppan, P.

AU - Chieco-Bianchi, L.

AU - Lise, M.

PY - 2001

Y1 - 2001

N2 - Background: Our aim was to ascertain whether or not the response to preoperative chemoradiotherapy for rectal cancer is associated with p27kip1 and p53 protein expression. Methods: Thirty-eight patients (27 male, 11 female) with a mean age of 59 years (age range 33-87) and stage II-III rectal cancer received preoperative chemoradiotherapy (45-50.4 Gy; 5-FU 350 mg/m2/day and leucovorin 10 mg/m2/day). Thirty-one underwent low anterior resection; seven underwent abdominoperineal excision. Endoscopic tumor biopsies, performed before adjuvant therapy, were evaluated for: histologic type, tumor differentiation, mitotic index, and p27kip1 and p53 protein expression which were immunohistochemically determined. p53 expression was graded as: a) absent or present in ≤10% of tumor cells; b) present in 11-25%; c) present in 26-75%; and d) present in >75% of tumor cells. p27kip1 expression was assessed using both light microscopy (percent of stained cells x10 HPF) and cytometry with an image analysis workstation. Tumor response, ascertained with histology, was classified using a scale from 0 (no response) to 6 (complete pathologic response). Results: The mitotic index for the endoscopic biopsies was low in 14 cases, moderate in 17 cases, and high in 7 cases. p53 protein expression was found in 21 (a), 3 (b), 3 (c), and 11 (d) cases. The mean percentage of cells expressing the p27kip1 protein was 34 (range 0-77.14%). A close correlation was found between cytometric and light microscopy findings for p27kip1 (r2 = 0.92, P = .0001). Tumor differentiation was good in 5 cases, poor in 2 cases, and moderate in the remaining 31 cases. While the response to adjuvant therapy was good/complete in 25 (65.78%) cases, it was absent/poor in 13 (34.21%) cases. Univariate analysis associated type of adjuvant therapy (chemoradiotherapy, P = .0428) and p27kip1 protein lower expression (P = .0148) with a poor response to adjuvant treatment. Stepwise linear regression found overexpression of p53 and p27kip1 and young age to be independent variables that were linked to a good response to adjuvant therapy. Conclusions: Lack of p27kip1 and p53 protein expression in rectal cancer is associated with a poor response to preoperative adjuvant therapy.

AB - Background: Our aim was to ascertain whether or not the response to preoperative chemoradiotherapy for rectal cancer is associated with p27kip1 and p53 protein expression. Methods: Thirty-eight patients (27 male, 11 female) with a mean age of 59 years (age range 33-87) and stage II-III rectal cancer received preoperative chemoradiotherapy (45-50.4 Gy; 5-FU 350 mg/m2/day and leucovorin 10 mg/m2/day). Thirty-one underwent low anterior resection; seven underwent abdominoperineal excision. Endoscopic tumor biopsies, performed before adjuvant therapy, were evaluated for: histologic type, tumor differentiation, mitotic index, and p27kip1 and p53 protein expression which were immunohistochemically determined. p53 expression was graded as: a) absent or present in ≤10% of tumor cells; b) present in 11-25%; c) present in 26-75%; and d) present in >75% of tumor cells. p27kip1 expression was assessed using both light microscopy (percent of stained cells x10 HPF) and cytometry with an image analysis workstation. Tumor response, ascertained with histology, was classified using a scale from 0 (no response) to 6 (complete pathologic response). Results: The mitotic index for the endoscopic biopsies was low in 14 cases, moderate in 17 cases, and high in 7 cases. p53 protein expression was found in 21 (a), 3 (b), 3 (c), and 11 (d) cases. The mean percentage of cells expressing the p27kip1 protein was 34 (range 0-77.14%). A close correlation was found between cytometric and light microscopy findings for p27kip1 (r2 = 0.92, P = .0001). Tumor differentiation was good in 5 cases, poor in 2 cases, and moderate in the remaining 31 cases. While the response to adjuvant therapy was good/complete in 25 (65.78%) cases, it was absent/poor in 13 (34.21%) cases. Univariate analysis associated type of adjuvant therapy (chemoradiotherapy, P = .0428) and p27kip1 protein lower expression (P = .0148) with a poor response to adjuvant treatment. Stepwise linear regression found overexpression of p53 and p27kip1 and young age to be independent variables that were linked to a good response to adjuvant therapy. Conclusions: Lack of p27kip1 and p53 protein expression in rectal cancer is associated with a poor response to preoperative adjuvant therapy.

KW - Chemoradiotherapy

KW - p27

KW - p53

KW - Rectal cancer

UR - http://www.scopus.com/inward/record.url?scp=0034744271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034744271&partnerID=8YFLogxK

U2 - 10.1245/aso.2001.8.4.311

DO - 10.1245/aso.2001.8.4.311

M3 - Article

C2 - 11352304

AN - SCOPUS:0034744271

VL - 8

SP - 311

EP - 318

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 4

ER -